Can light therapy reverse age-related visual decline? Mitochondrial decline due to aging causes visual decline to begin around age 40. Light and laser therapies have extensive research, wide range of applications, and are safe. Published research is important. Aging increases injury risk and cellular decline. Mitochondrial decline and the impact on visual aging. Light therapy potential for improving age-related vision decline, emphasizing importance of research.
Mitochondrial decline leads to age-related visual decline, but red light therapy can recharge mitochondria and potentially reverse the decline.
A study showed that red light therapy improved rod and cone function in individuals above the age of 38, bringing their vision closer to younger levels without subjective changes in vision perception.
Deep dives
Age-Related Decline in Vision
As we age, our eyes undergo certain changes and cellular decline, leading to a decline in vision. These age-related changes include injuries, overuse, and a decline in cellular function, particularly in the mitochondria, which produce cellular energy. Mitochondrial decline affects the functioning of the retina, leading to reduced rod and cone performance. However, a study published in 2020 revealed that red light therapy, aimed at improving mitochondrial function, can help mitigate age-related decline in vision.
Optically Improved Mitochondrial Function and Visual Decline
The study conducted home-based red light therapy treatments on participants aged 28 to 72. Only individuals above the age of 38 showed significant improvements in rod and cone function after two weeks of daily three-minute treatments. Younger participants did not exhibit any changes. The study concluded that red light therapy can improve vision thresholds and bring them closer to levels seen in younger individuals. Notably, the therapy did not elicit any subjective changes in vision perception, despite objective improvements in retinal performance.
The Promising Benefits of Light Therapy
Studies like this signify progress towards reversing age-related changes through light therapy. Unlike medications, light therapy poses minimal risks and side effects. Such therapy shows potential not only for age-related vision decline but for other conditions as well. The emergence of home-based light therapy devices offers convenience and potential benefits, but caution is advised in selecting FDA-cleared and safety-supervised devices. Consulting a Laser Therapy Institute clinic is recommended for optimal treatment guidance and safety practices.
Mitochondrial decline due to aging causes visual decline to begin around the age of 40, and by age 70, approximately 30% of your retinal rods have died and the cones have significantly reduced function. Can light therapy, or photobiomodulation, be used to recharge the mitochondria and thus reduce or even reverse age-related visual decline? Join Dr. Rountree and Kristi as they discuss a 2020 study on light therapy and visual decline.
We have begun live-streaming this podcast. Watch this episode on Facebook right here, and see the next episode LIVE in two weeks!